Danish company O2matic, in collaboration with Hvidovre Hospital, has developed an oxygen robot that can improve the oxygen supply to coronavirus patients.
The robot, already being used at Hvidovre Hospital, can deliver the correct amount of oxygen to patients which limits the contact healthcare staff have with coronavirus patients, thus reducing the contamination risk.
“The corona pandemic has cast us into a unique situation which requires new solutions. The concept of the O2matic oxygen robot is such a solution,” said Chairman of Capital Region of Denmark, Sophie Hæstorp Andersen.
“In my opinion this proves once again that our healthcare professionals are fantastic at solving even the most difficult situations when it comes to saving lives.”
Last weekend, the first coronavirus patients were treated by O2matic’s oxygen robot with good results.
Based on this, The Capital Region of Denmark has ordered 40 oxygen robots for use at hospitals in the region.
“It is hugely gratifying that our robot can make a difference for the people critically affected by the corona pandemic,” said Farzad Saber, Chief Product Officer of O2matic.
“Our oxygen robot ensures that patients receive the correct amount of oxygen. This will alleviate the pressure on healthcare staff in hospitals and reduce the need for frequent checkups and thereby also the risk of infection.”
The development of the oxygen robot is funded by multiple investors and funds, including the Innovation Fund Denmark investment, and O2matic recently won the Innovation Fund Denmark’s main research prize, The Grand Solutions Prize, at the annual prize ceremony.
O2matic is already preparing production of the next 500 oxygen robots, which are all produced by the high-tech company, Alpha Electronics in Denmark.